1
One complete case
Investor information • Public overview
Build the decision layer before trying to scale the market.
WHITEGLOVEMD begins with one difficult, high-stakes workflow: helping a patient and family understand a heart-surgery decision through one complete record, two specialty perspectives, and one physician-reviewed report.
No public forecast, fundraising term, or unaudited traction claim is presented on this page.
WHITEGLOVEMDCurrent service
One cardiac decisionorganized for the next conversation.
The operating thesis
The hard part is not generating more information. It is making one complete case usable.
Heart-surgery decisions can involve competing procedural paths, incomplete records, different specialty perspectives, individualized risk, and questions about where care should occur.
The initial company thesis is intentionally focused: build a disciplined cardiac-review service first, learn where the workflow creates durable value, and expand only when the evidence and operating requirements support it.
The current product
A service that can be understood end to end.
These are the patient-facing capabilities represented as available today. Roadmap concepts are labeled separately below.
2
Two specialty perspectives
A cardiac surgeon and cardiologist review the same record.
The operative and cardiology perspectives are developed independently, reconciled, and preserved when the evidence supports more than one reasonable path.3
One usable deliverable
The physicians review and co-sign the final report.
The patient receives a structured, patient-facing report that organizes clinical context, risk, alternatives, missing information, questions, and practical next steps.Clinical boundary
WHITEGLOVEMD provides educational decision support and independent medical-record review. It does not diagnose, prescribe, provide emergency care, or replace the clinicians responsible for treatment.
Read the medical disclaimerCurrent versus future
A public investor page should separate operation from ambition.
That distinction is part of the product discipline—not a footnote.
1Available now
Patient-paid cardiac review
The current service supports patients facing a heart-surgery decision with records assistance, independent dual-specialist review, and a written report. Live physician consultation is available in selected packages.
See the patient entry point2Current build focus
Clinical fidelity and repeatable operations
The near-term work is deliberately narrow: reliable record intake, source-linked preparation, physician review, report quality, access coordination, and responsible outcomes follow-up.
Review the clinical standard3Requires validation
Enterprise and specialty expansion
Hospital workflows, payer use cases, deeper integrations, and additional specialties are roadmap opportunities—not represented here as deployed products, contracted relationships, or guaranteed markets.
See the hospital boundaryWhat may become durable
The investable work sits inside the operating method.
These are design priorities and areas of continued build—not claims of an unassailable moat or proven superiority.
Examine the review standardClinical ownership
Technology can assist with record organization and structured preparation. The assigned physicians remain responsible for interpretation, revisions, conclusions, and signatures.
Traceable evidence
Important facts should remain connected to their source material, with missing or conflicting information made visible rather than smoothed over.
Workflow discipline
A consistent intake, completeness gate, independent review, reconciliation, and delivery process can make a complex service easier to operate and evaluate.
Patient usefulness
The output is designed for the next real conversation: what is known, what remains uncertain, which alternatives matter, and what should be asked next.
Disciplined expansion
Prove one layer before adding the next.
Sequence matters. Each later phase depends on clinical, technical, commercial, legal, and operational validation that cannot be assumed in advance.
NowCurrent operation
Prove the cardiac review workflow
Serve patients responsibly, harden the end-to-end operating system, and measure what happens after the report without overstating early evidence.
NextValidation required
Test institution-ready delivery
Define scoped use cases with hospitals, employers, or payers only after workflow, security, legal, integration, and measurement requirements are understood.
LaterRoadmap hypothesis
Adapt the method to adjacent decisions
Evaluate other high-stakes specialties one at a time. Each expansion would require its own clinical expertise, evidence base, review logic, governance, and operating proof.
Evidence before narrative
Measure the decision, the action, and the outcome separately.
A useful company dataset must distinguish what the treating team initially proposed, what the independent review added, what the patient ultimately chose, and what happened afterward. Early signals should not be presented as mature outcome evidence.
1
Did the review surface a material difference or missing question?
2
What decision did the patient and treating team ultimately make?
3
What clinical, experience, access, and cost outcomes followed?
4
Which findings can be supported at cohort scale rather than anecdote?
Investor questions
Start with what is true today.
Confidential information belongs in a contextual conversation, not in unsupported public claims.
Contact the founderWhat does WHITEGLOVEMD offer today?+
The current patient service provides records support, independent review by a cardiac surgeon and cardiologist, and a co-signed WHITEGLOVE Insights™ report for a heart-surgery decision. Live physician consultation is available in selected packages.
What role does technology play in the review?+
Technology can assist with record organization and structured preparation. It does not replace the physicians assigned to the case. Those physicians are responsible for the clinical interpretation, edits, conclusions, and signatures in the final report.
Is WHITEGLOVEMD already an enterprise platform?+
The public service available today is the patient cardiac-review workflow. Hospital, payer, employer, integration, and multi-specialty opportunities are roadmap or organization-specific possibilities that require validation; this page does not imply a deployed integration or contracted relationship.
Why begin with cardiac surgery?+
Heart-surgery decisions bring anatomy, medical therapy, catheter-based alternatives, operative technique, risk, and center experience into one time-sensitive choice. That makes the specialty a demanding place to prove a dual-specialist review workflow.
Where are traction, financial, and fundraising details?+
WHITEGLOVEMD does not publish unaudited operating metrics, forecasts, financing terms, or confidential materials on this public page. Appropriate information can be shared directly with qualified prospective investors, subject to context and confidentiality.
How can a prospective investor start a conversation?+
Use the investor email link on this page and include your name, organization, investment focus, and the reason WHITEGLOVEMD is relevant to your work. The team will respond if there is a useful fit for a direct conversation.
Investor contact
If the narrow wedge makes sense, let’s discuss the evidence behind it.
Introduce yourself, your investment focus, and the question you want to explore. Relevant operating and financing information can be discussed directly with appropriate context.
Request an investor conversationThis public page is for general informational purposes only. It is not an offer to sell, or a solicitation of an offer to buy, any security. Roadmap statements describe present goals and hypotheses, not commitments, forecasts, or guarantees.